FDA Inspection 1244660 - Gland Pharma Limited, Units I+II Pashamylaram Site - August 02, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Gland Pharma Limited, Units I+II Pashamylaram Site

Record Details

This FDA Inspection record concerns Gland Pharma Limited, Units I+II Pashamylaram Site, with an inspection on August 2, 2024, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Gland Pharma Limited, Units I+II Pashamylaram Site
Inspection Date: August 2, 2024
Product Type: Human Drugs
Office: Office of Inspections and Investigations

Open in Dashboard

ID · 9a9126ce-3d6e-4ad7-891a-5cdd10d186bd

Violation Codes3

21 CFR 211.113(b)21 CFR 211.22(d)21 CFR 211.42(c)(10)(iv)

Full citation text and observation details available on the Dashboard.